Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 54684461Generated: October 23, 2026

Invertin

Doxycycline USP · DOXYCYCLINE HYDRATE · Power v1 · NSC-56228 · Strong v1 · Doxycyeline HCL · oxycyclinemonohydrate · DOXYCYCLINE MONOHYDRATE

https://huagongshe.com/en/chemical/54684461

Invertin molecular structure

Identifiers & Physical Properties

CAS No.17086-28-1
Molecular formulaC22H26N2O9
Average molar mass462.4 g/mol
SMILESC[C@H]1c2cccc(O)c2C(O)=C2C(=O)[C@]3(O)C(O)=C(C(N)=O)C(=O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O
InChIKeyXQTWDDCIUJNLTR-PGTYNCOMNA-N
PubChem CID54684461
ChEMBLCHEMBL1200699
ChEBICHEBI:60648
EC No.605-591-4
DTXSIDDTXSID401045241

Chemical & Physical Properties

Topological polar surface area183
Hydrogen bond donors7
Hydrogen bond acceptors10
Rotatable bonds2
Heavy atoms33
Formal charge0
Complexity956
DrugsPharmaceuticals -> Antibiotics
Melting point167-168℃
Storage conditionsSealed in dry,Store in freezer, under -20°C
SolubilityDMSO: soluble1mg/mLSoluble in ethanol or methanol. Sparingly soluble in water.Soluble in dilute acids, alkali hydroxides and dimethyl sulfoxide.
Physical statepowder or crystals
ColorLight Yellow
Major applicationspharmaceutical (small molecule)
InChIKeyXQTWDDCIUJNLTR-PGTYNCOMNA-N
SMILES[C@@]12([H])[C@@H](O)[C@@]3([H])C(C(=O)C4C(O)=CC=CC=4[C@@H]3C)=C(O)[C@]1(O)C(=O)C(C(=O)N)=C(O)[C@H]2N(C)C.O |&1:0,2,4,16,20,30,r|
CAS DataBase Reference17086-28-1
FDA UNIIN12000U13O
Proposition 65 ListDoxycycline Monohydrate (internal use)
UNSPSC Code41116107
NACRESNA.24
GHS pictogramGHS07
Signal wordWarning
GHS hazard statementsH302
GHS precautionary statementsP264-P270-P301+P312+P330-P501
Hazard symbolsXi,Xn
Risk statements (R)36/37/38-22-63
Safety statements (S)26-36/37
Water hazard class (WGK)3
Customs code29413000
Storage class11 - Combustible Solids
Hazard classAcute Tox. 4 Oral

Safety & Regulations

GHS classificationDangerH302 (43.2%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 148 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Regulatory informationHazard Traits - Developmental ToxicityDoxycycline monohydrate: Does not have an individual approval but may be used under an appropriate group standardInvertin: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and CategoriesAcute Tox. 4 (43.2%)
Water hazard class (WGK)3
Customs code29413000
Risk statements (R)36/37/38-22-63
Signal wordWarning
GHS pictogramGHS07
Hazard symbolsXi,Xn
Safety statements (S)26-36/37
Storage class11 - Combustible Solids
GHS hazard statementsH302
Hazard classAcute Tox. 4 Oral
GHS precautionary statementsP264-P270-P301+P312+P330-P501

Applications & Uses

Description

Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline. It is a semi-synthetic tetracycline. Doxycycline penetrates the bacterial cell and interferes with the protein biosynthesis, stopping the process. Other microorganisms are also sensitive to the antibiotic activity of Doxycycline, such as Mycoplasma, Chlamydia and Ricketsiae. Resistance to antibiotics of the tetracycline family is primarily due to inhibition of transport of the drug into the cell or by increasing antibiotic efflux. The biological mechanism is mainly through plasmid mediation but it may also occur by chromossomal alteration.

Uses

Doxycycline Monohydrate is used to treat bacterial infections, Lyme disease, chlamydia, Rocky Mountain Spotted Fever, and other susceptible bacterial infections. It is an antibiotic with bacteriostatic properties.Tetracycline antibacterial.

Uses

An antimicrobial. Inhibits angiogenesis and reduces lung metastases by inhibiting matrix metalloproteinasesDoxycycline monohydrate acts as an antibiotic, antimicrobial agent and a matrix metalloproteinase inhibitor. It is also used for the treatment of chloroquine-resistant falciparum malaria. Further, it is used to treat a wide variety of bacterial infections, including those that cause acne. In addition to this, it inhibits the bacterial protein synthesis by preventing the interaction of aminoacyl-tRNA and the bacterial ribosome.

General Description

Doxycycline was synthesized by Pfizer starting with either tetracycline or oxytetracycline in 1958. It shows about fourfold higher antibacterial activity than tetracycline against a variety of pathogens. Doxycycline shows higher oral absorption than tetracycline, and its concentration in tissue is higher and maintained longer. Hyclate is a preparation of doxycycline containing one mole of hydrochloric acid and one-half mole each of ethanol and water per mole of doxycycline.